Johnson & Johnson (NYSE:JNJ – Get Loose Record) used to be upgraded through StockNews.com from a “purchase” score to a “strong-buy” score in a analysis document issued on Tuesday.

A number of different equities analysis analysts additionally not too long ago weighed in at the inventory. TheStreet downgraded stocks of Johnson & Johnson from a “b” score to a “c+” score in a analysis notice on Friday, November seventeenth. Cantor Fitzgerald reissued an “obese” score and issued a $215.00 worth function on stocks of Johnson & Johnson in a analysis document on Tuesday, January twenty third. Morgan Stanley decreased their worth goal on Johnson & Johnson from $170.00 to $169.00 and set an “equivalent weight” score for the corporate in a document on Wednesday, January twenty fourth. Raymond James raised their worth goal on Johnson & Johnson from $172.00 to $175.00 and gave the inventory an “outperform” score in a document on Wednesday, January third. After all, UBS Staff upgraded stocks of Johnson & Johnson from a “impartial” score to a “purchase” score and lifted their goal worth for the inventory from $167.00 to $180.00 in a analysis notice on Friday, December 1st. 8 analysis analysts have rated the inventory with a hang score, 5 have issued a purchase score and one has issued a robust purchase score to the corporate’s inventory. In line with MarketBeat.com, the corporate at this time has a consensus score of “Average Purchase” and a consensus goal worth of $176.14.

Learn Our Newest Analysis Record on JNJ

Johnson & Johnson Buying and selling Down 0.1 %

JNJ inventory opened at $157.98 on Tuesday. The corporate has a debt-to-equity ratio of 0.37, a present ratio of one.21 and a snappy ratio of 0.96. The company’s 50-day shifting reasonable is $158.20 and its 200 day shifting reasonable is $159.04. The corporate has a marketplace capitalization of $380.30 billion, a PE ratio of eleven.44, a P/E/G ratio of two.62 and a beta of 0.53. Johnson & Johnson has a 12 month low of $144.95 and a 12 month top of $175.97.

Johnson & Johnson (NYSE:JNJ – Get Loose Record) remaining introduced its profits effects on Tuesday, January twenty third. The corporate reported $2.29 profits in keeping with proportion (EPS) for the quarter, beating the consensus estimate of $2.28 through $0.01. Johnson & Johnson had a go back on fairness of 36.75% and a web margin of 37.79%. The industry had income of $21.40 billion for the quarter, in comparison to analysts’ expectancies of $21.02 billion. Throughout the similar quarter remaining yr, the company earned $2.35 EPS. The industry’s income for the quarter used to be down 9.7% on a year-over-year foundation. On reasonable, analysis analysts look ahead to that Johnson & Johnson will submit 10.66 EPS for the present yr.

Institutional Buying and selling of Johnson & Johnson

Plenty of hedge price range and different institutional buyers have not too long ago made adjustments to their positions within the corporate. Partnership Wealth Control LLC bought a brand new stake in Johnson & Johnson throughout the fourth quarter value $1,602,000. Wambolt & Pals LLC larger its place in stocks of Johnson & Johnson through 4.5% throughout the 4th quarter. Wambolt & Pals LLC now owns 14,668 stocks of the corporate’s inventory value $2,299,000 after buying an extra 625 stocks throughout the remaining quarter. Summitry LLC larger its place in stocks of Johnson & Johnson through 5.0% throughout the fourth quarter. Summitry LLC now owns 29,571 stocks of the corporate’s inventory valued at $4,635,000 after obtaining an extra 1,410 stocks throughout the remaining quarter. Predominant Monetary Staff Inc. larger its place in stocks of Johnson & Johnson through 1.2% throughout the fourth quarter. Predominant Monetary Staff Inc. now owns 3,139,566 stocks of the corporate’s inventory valued at $492,096,000 after obtaining an extra 37,131 stocks throughout the remaining quarter. After all, USA Monetary Formulation larger its place in stocks of Johnson & Johnson through 4,809.1% throughout the fourth quarter. USA Monetary Formulation now owns 1,620 stocks of the corporate’s inventory valued at $254,000 after obtaining an extra 1,587 stocks throughout the remaining quarter. Institutional buyers and hedge price range personal 68.40% of the corporate’s inventory.

About Johnson & Johnson

(Get Loose Record)

Johnson & Johnson, along side its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being phase supplies pores and skin well being/attractiveness merchandise beneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise beneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise beneath the LISTERINE logo; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and hypersensitive reaction merchandise; BENADRYL and ZYRTEC hypersensitive reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disease merchandise.

Really helpful Tales

Obtain Information & Rankings for Johnson & Johnson Day-to-day – Input your e-mail deal with underneath to obtain a concise day-to-day abstract of the most recent information and analysts’ rankings for Johnson & Johnson and similar corporations with MarketBeat.com’s FREE day-to-day e-mail e-newsletter.